LycoRed versus Parry and Valensa in court

LycoRed Limited and LycoRed Corporation ("LycoRed"), leading developers and marketers of ingredients for food fortification, dietary supplements and food colouring, including Lyc-O-Mato lycopene product, announced today that on March 19 they filed a lawsuit against E.I.D. Parry Ltd. and Valensa International for patent infringement.

LycoRed, a science-based Israeli company with over 15 years of experience, claims Parry infringed upon three patents, violating the company's science on the composition, process and applications for lycopene products. The lawsuit was filed in U.S. District Court, District of New Jersey, for infringement of U.S. Patent Nos. 6,515,018; 5,837,311; and 5,965,183.

LycoRed alleges that Parry/Valensa engaged in acts of infringement by making, using and selling its tomato lycopene products in the United States, and has therefore placed its customers in the position of doing so as well.

LycoRed is asking the Court to grant an injunction to stop sales of, and to recall, all products that infringe on the noted patents and to award damages to compensate the company for the unlawful violations.

“Parry Nutraceuticals unlawfully leveraged our proprietary science to produce and market its tomato lycopene complex,” said Morris Zelkha, president and CEO of LycoRed. "Parry, however, has not offered any scientific research to demonstrate that its lycopene products have the same clinical attributes as Lyc-O-Mato." Lyc-O-Mato has a unique patented particle size of less than five microns and is supported by clinical studies demonstrating high bioavailability and absorption.

For more information please contact:
Dr. Yoav Blatt
LycoRed
[email protected]
www.lycored.com